Fellowship in Rheumatology at Northwell Health
Thank you for your interest in the Northwell Rheumatology Fellowship Program. This program provides comprehensive training in clinical and investigative rheumatology and related basic science to prepare rheumatologists for careers in clinical practice and/or investigative rheumatology. The fellowship program is fully integrated into the activities of the Division of Rheumatology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Centers for Autoimmune and Musculoskeletal Diseases and Genetics at the Feinstein Institute for Medical Research. It includes at least 12 months of clinical training and nine to 24 months of a focused research experience.
We offer two tracks for board-eligible internists:
- Our two-year track currently offers two positions each year to board-eligible internists who have completed three years of training in Internal Medicine at an accredited U.S. or Canadian training program.
- Our three year track offers one position to a board-eligible internist who has completed three years of training in Internal Medicine at an accredited U.S. or Canadian training program and who is interested in extended research training (basic, translational or clinical) leading to an academic career path.
The two-year subspecialty program provides supervised training at a level that allows the fellow to acquire the expertise and competency of a specialist in rheumatology. Each fellow must conform to the requirements of the Accreditation Council of Graduate Medical Education. We offer a closely mentored experience in the diagnosis and management of patients with rheumatic diseases in both inpatient and ambulatory settings. Fellows are required to participate in scholarly activities involving teaching and both basic and clinical research.
The three-year program provides the same clinical training but allows fellows who have committed to a research path to integrate research activities even in the first year of fellowship. A postgraduate PhD or MPH program can be linked to the fellowship program for those interested in pursuing a career in academic medicine.
The clinical training occurs in two tertiary care institutions, Long Island Jewish Medical Center (LIJ) and North Shore University Hospital (NSUH). The nearly 1,800 inpatient beds and two active emergency departments in our hospitals provide the trainee with exposure to large numbers of acutely ill patients. Fellows also participate in continuity care clinic experiences in both institutions and spend one half day per week in the faculty outpatient practices for a total three half days per week throughout the length of the training period.
The program includes training in the performance of joint aspirates, joint and soft tissue injections, the infusion of biologic agents, the performance and interpretation of joint ultrasound, as well as participation in clinical trials. The presence of accredited subspecialty programs in other disciplines on campus fosters peer interactions that create an outstanding learning environment for rheumatology fellows.
Elective rotations enable the trainee to develop skills in allied areas, including:
- Pediatric rheumatology
- Rehabilitation medicine
- Sports medicine
- Skeletal radiology
- Metabolic bone
- Nuclear medicine
There is a weekly conference schedule that includes clinical, core and multidisciplinary conferences, case presentations, radiology, journal clubs and a roster of invited speakers. Opportunities for teaching residents and medical students for continuing medical education at regional and national conferences and workshops are plentiful.
In their second year, fellows choose an area of clinical or basic science research and actively pursue it under the guidance of a faculty member. The Autoimmune and Musculoskeletal Diseases Center and the Boas Center for Genetics at the Feinstein Institute for Medical Research provide opportunities to participate in investigator-initiated clinical trials and in basic and translational research and to take rigorous courses in investigative medicine and in statistics.
A three-year post-MD PhD training program at the Feinstein Institute is available through the Elmezzi program and can be started in the second year of fellowship. A two-year MPH program is offered by Hofstra University.
Applicants interested in the rheumatology fellowship training program at Northwell Health should apply through the Electronic Residency Application Service (ERAS), which allow applications starting July 1.
There are two two-year and one three-year fellowship positions available for physicians who have completed a USMLE accredited internal medicine residency-training program. Those applying for a three-year program will have the opportunity to meet research faculty at the Feinstein Institute for Medical Research as well as clinical faculty on the day of interview.
The fellowship application deadline is August 11, 2018. Completed applications submitted before August 1 are given preference. Note that the two-year and three-year positions are listed as separate tracks in ERAS and separate rank lists will be created for each track.
Essential application information includes:
- Curriculum vitae
- Four letters of recommendation
- USMLE or COMLEX results
- Common application
- Medical school transcript
- Program director’s letter of recommendation
2019 – 2020 graduating fellows:
Bhakti Shah 2017-19
Lara El-Khoury 2017-19
Jonathan Paramo 2018-20
Rishi Patel 2018-20
Erik Anderson 2015-19 (Elmezzi scholar)
Nina Kello 2016-19 (3 year program)
Anne Davidson, MBBS
Fellowship Program Director, Division of Rheumatology
Investigator, Feinstein Institute for Medical Research
Professor of Molecular Medicine, Zucker School of Medicine
Dr. Davidson is interested in immune tolerance and renal inflammation in SLE. Her research laboratory is at the Feinstein Institute.
ABIM status: Board Certified in Rheumatology.
Cynthia Beth Aranow, MD
Investigator, Center for Autoimmune and Musculoskeletal Disorders, Feinstein Institute for Medical Research
Associate Professor of Molecular Medicine and Medicine, Zucker School of Medicine
Maria-Louise Barilla-Labarca, MD
Associate Professor, Zucker School of Medicine
Betty Diamond, MD
Investigator & Head, Center for Autoimmune and Musculoskeletal Diseases,The Feinstein Institute for Medical Research
Professor of Molecular Medicine and Medicine, Zucker School of Medicine
Richard A. Furie, MD
Investigator, The Feinstein Institute for Medical Research
Chief, Division of Rheumatology and Allergy-Clinical Immunology, Northwell Health
Director, Program in Novel Therapeutics
Professor, Zucker School of Medicine
Professor, Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Diane Michelle Horowitz, MD
Assistant Professor, Zucker School of Medicine
Meggan Claire Mackay, MD
Investigator, Autoimmune & Musculoskeletal Disorders, The Feinstein Institute for Medical Research
Associate Professor, Molecular Medicine and Medicine, Zucker School of Medicine
Galina S. Marder, MD
Director - Myositis and Vasculitis Center, Long Island Jewish Medical Center
Assistant Professor, Zucker School of Medicine
Julie Schwartzman-Morris, MD
Associate Professor, Zucker School of Medicine
Sonali Narain, MD
Assistant Professor, Zucker School of Medicine
Christine Stamatos DNP, ANP-C
Fibromyalgia Wellness Center
Undergraduate: Georgetown University BSN
Graduate: Stony Brook University
Focus on pharmacological and non pharmacological strategies to manage chronic pain
1: Furie RA, Wallace DJ, Aranow C, Fettiplace J, Wilson B, Mistry P, Roth DA, Gordon D. Long-term safety and efficacy of belimumab in patients with systemic lupus erythematosus: a continuation of the Phase 3 United States BLISS-76 trial. Arthritis Rheumatol. 2018 Feb 6. doi: 10.1002/art.40439. [Epub ahead of print] PubMed PMID: 29409143.
2: Anderson E, Shah B, Davidson A, Furie R. Lessons learned from bone marrow failure in systemic lupus erythematosus: Case reports and review of the literature. Semin Arthritis Rheum. 2017 Dec 8. pii: S0049-0172(17)30383-9. doi: 10.1016/j.semarthrit.2017.12.004. [Epub ahead of print] PubMed PMID: 29395255.
3: Furie R, Khamashta M, Merrill JT, Werth VP, Kalunian K, Brohawn P, Illei GG, Drappa J, Wang L, Yoo S; CD1013 Study Investigators. Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus. Arthritis Rheumatol. 2017 Feb;69(2):376-386. doi: 10.1002/art.39962. PubMed PMID: 28130918; PubMed Central PMCID: PMC5299497.
4: Menard LC, Habte S, Gonsiorek W, Lee D, Banas D, Holloway DA, Manjarrez-Orduno N, Cunningham M, Stetsko D, Casano F, Kansal S, Davis PM, Carman J, Zhang CK, Abidi F, Furie R, Nadler SG, Suchard SJ. B cells from African American lupus patients exhibit an activated phenotype. JCI Insight. 2016 Jun 16;1(9):e87310. PubMed PMID: 27699274; PubMed Central PMCID: PMC5033941.
5: Malkiel S, Barlev AN, Atisha-Fregoso Y, Suurmond J, Diamond B. Plasma Cell Differentiation Pathways in Systemic Lupus Erythematosus. Front Immunol. 2018 Mar 5;9:427. doi: 10.3389/fimmu.2018.00427. eCollection 2018. Review. PubMed PMID: 29556239; PubMed Central PMCID: PMC5845388.
6: Mader S, Jeganathan V, Arinuma Y, Fujieda Y, Dujmovic I, Drulovic J, Shimizu Y, Sakuma Y, Stern JNH, Aranow C, Mackay M, Yasuda S, Atsumi T, Hirohata S, Diamond B. Understanding the Antibody Repertoire in Neuropsychiatric Systemic Lupus Erythematosus and Neuromyelitis Optica Spectrum Disorder: Do They Share Common Targets? Arthritis Rheumatol. 2018 Feb;70(2):277-286. doi: 10.1002/art.40356. Epub 2018 Jan 9. PubMed PMID: 29073350.
7: Kim SJ, Schätzle S, Ahmed SS, Haap W, Jang SH, Gregersen PK, Georgiou G, Diamond B. Increased cathepsin S in Prdm1(-/-) dendritic cells alters the T(FH) cell repertoire and contributes to lupus. Nat Immunol. 2017 Sep;18(9):1016-1024. doi: 10.1038/ni.3793. Epub 2017 Jul 10. PubMed PMID: 28692065; PubMed Central PMCID: PMC5568473.
8: Son M, Diamond B, Volpe BT, Aranow CB, Mackay MC, Santiago-Schwarz F. Evidence for C1q-mediated crosslinking of CD33/LAIR-1 inhibitory immunoreceptors and biological control of CD33/LAIR-1 expression. Sci Rep. 2017 Mar 21;7(1):270. doi: 10.1038/s41598-017-00290-w. PubMed PMID: 28325905; PubMed Central PMCID: PMC5412647.
9: Jang SH, Chen H, Gregersen PK, Diamond B, Kim SJ. Kruppel-like factor4 regulates PRDM1 expression through binding to an autoimmune risk allele. JCI Insight. 2017 Jan 12;2(1):e89569. doi: 10.1172/jci.insight.89569. PubMed PMID: 28097234; PubMed Central PMCID: PMC5214232.
10: Mackay M, Oswald M, Sanchez-Guerrero J, Lichauco J, Aranow C, Kotkin S, Korsunsky I, Gregersen PK, Diamond B. Molecular signatures in systemic lupus erythematosus: distinction between disease flare and infection. Lupus Sci Med. 2016 Nov 10;3(1):e000159. eCollection 2016. PubMed PMID: 27933197; PubMed Central PMCID: PMC5133406.
11: Son M, Porat A, He M, Suurmond J, Santiago-Schwarz F, Andersson U, ColemanTR, Volpe BT, Tracey KJ, Al-Abed Y, Diamond B. C1q and HMGB1 reciprocally regulate human macrophage polarization. Blood. 2016 Nov 3;128(18):2218-2228. Epub 2016 Sep 28. PubMed PMID: 27683415; PubMed Central PMCID: PMC5095756.
12: Narain S, Furie R. Update on clinical trials in systemic lupus erythematosus. Curr Opin Rheumatol. 2016 Sep;28(5):477-87. doi: 10.1097/BOR.0000000000000311. Review. PubMed PMID: 27314466.
13: Aggarwal R, Marder G, Koontz DC, Nandkumar P, Qi Z, Oddis CV. Efficacy and safety of adrenocorticotropic hormone gel in refractory dermatomyositis and polymyositis. Ann Rheum Dis. 2017 Dec 13. pii: annrheumdis-2017-212047. doi: 10.1136/annrheumdis-2017-212047. [Epub ahead of print] PubMed PMID: 29237618.
14: Bottai M, Tjärnlund A, Santoni G, Werth VP, Pilkington C, de Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA, Aggarwal R, Arnardottir S, Chinoy H, Cooper RG, Danko K, Dimachkie MM, Feldman BM, García-De La Torre I, Gordon P, Hayashi T, Katz JD, Kohsaka H, Lachenbruch PA, Lang BA, Li Y, Oddis CV, Olesinka M, Reed AM, Rutkowska-Sak L, Sanner H, Selva-O'Callaghan A, Wook Song Y, Vencovsky J, Ytterberg SR, Miller FW, Rider LG, Lundberg IE; International Myositis Classification Criteria Project consortium, the Euromyositis register and the Juvenile Dermatomyositis Cohort Biomarker Study and Repository (JDRG) (UK and Ireland) . EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report. RMD Open. 2017 Nov 14;3(2):e000507. doi: 10.1136/rmdopen-2017-000507. eCollection 2017. PubMed PMID: 29177080; PubMed Central PMCID: PMC5687535.
15: Aggarwal R, Rider LG, Ruperto N, Bayat N, Erman B, Feldman BM, Oddis CV, Amato AA, Chinoy H, Cooper RG, Dastmalchi M, Fiorentino D, Isenberg D, Katz JD, Mammen A, de Visser M, Ytterberg SR, Lundberg IE, Chung L, Danko K, García-De la Torre I, Song YW, Villa L, Rinaldi M, Rockette H, Lachenbruch PA, Miller FW, Vencovsky J; International Myositis Assessment and Clinical Studies Group and the Paediatric Rheumatology International Trials Organisation. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.Arthritis Rheumatol. 2017 May;69(5):898-910. doi: 10.1002/art.40064. Epub 2017 Apr 6. PubMed PMID: 28382787; PubMed Central PMCID: PMC5407906.
16: Berman JR, Aizer J, Bass AR, Blanco I, Davidson A, Dwyer E, Fields TR, Huang WT, Kang JS, Kerr LD, Krasnokutsky-Samuels S, Lazaro DM, Schwartzman-Morris JS,Paget SA, Pillinger MH. Fellow use of medical jargon correlates inversely with patient and observer perceptions of professionalism: results of a rheumatology OSCE (ROSCE) using challenging patient scenarios. Clin Rheumatol. 2016 Aug;35(8):2093-2099. doi: 10.1007/s10067-015-3113-9. Epub 2015 Nov 20. PubMed PMID: 26585177.
17: Maria NI, Davidson A. Renal Macrophages and Dendritic Cells in SLE Nephritis. Curr Rheumatol Rep. 2017 Nov 9;19(12):81. doi: 10.1007/s11926-017-0708-y. Review. PubMed PMID: 29119288.
18: Berthier CC, Kretzler M, Davidson A. A systems approach to renal inflammation in SLE. Clin Immunol. 2017 Dec;185:109-118. doi: 10.1016/j.clim.2016.08.015. Epub 2016 Aug 14. Review. PubMed PMID: 27534926; PubMed Central PMCID: PMC5309209.
19: Boneparth A, Woods M, Huang W, Akerman M, Lesser M, Davidson A. The effect of BAFF inhibition on autoreactive B cell selection in murine SLE. Mol Med. 2016 Feb 12. doi: 10.2119/molmed.2016.00022. [Epub ahead of print] PubMed PMID: 26882090; PubMed Central PMCID: PMC5004722.
20: Stamatiades EG, Tremblay ME, Bohm M, Crozet L, Bisht K, Kao D, Coelho C, Fan X, Yewdell WT, Davidson A, Heeger PS, Diebold S, Nimmerjahn F, Geissmann F. Immune Monitoring of Trans-endothelial Transport by Kidney-Resident Macrophages. Cell. 2016 Aug 11;166(4):991-1003. doi: 10.1016/j.cell.2016.06.058. Epub 2016 Jul 28. PubMed PMID: 27477514; PubMed Central PMCID: PMC4983224.
21: Tsai F, Homan PJ, Agrawal H, Misharin AV, Abdala-Valencia H, Haines GK 3rd, Dominguez S, Bloomfield CL, Saber R, Chang A, Mohan C, Hutcheson J, Davidson A, Budinger GRS, Bouillet P, Dorfleutner A, Stehlik C, Winter DR, Cuda CM, Perlman H. Bim suppresses the development of SLE by limiting myeloid inflammatory responses. J Exp Med. 2017 Dec 4;214(12):3753-3773. doi: 10.1084/jem.20170479. Epub 2017 Nov 7. PubMed PMID: 29114065; PubMed Central PMCID: PMC5716039.
22: Little J, Parker B, Lunt M, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Buyon J, Isenberg DA, Rahman A, Ginzler EM, Petri M, Dooley MA, Fortin P, Gladman DD, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Sam Lim S, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Sanchez-Guerrero J, Bruce IN. Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort. Rheumatology (Oxford). 2018 Apr 1;57(4):677-687. doi: 10.1093/rheumatology/kex444. PubMed PMID: 29361147.
23: Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin P, Gladman DD, Bruce IN, Petri M, Ginzler EM, Dooley MA, Steinsson K, Ramsey-Goldman R, Zoma AA, Manzi S, Nived O, Jonsen A, Khamashta MA, Alarcón GS, Chatham W, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Ramos-Casals M, Lim SS, Inanc M, Kalunian KC, Jacobsen S, Peschken CA, Kamen DL, Askanase A, Theriault C, Farewell V. Cerebrovascular Events in Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2018 Jan 5. doi: 10.1002/acr.23509. [Epub ahead of print] PubMed PMID: 29316357.
24: Barber MRW, Hanly JG, Su L, Urowitz MB, Pierre YS, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Fortin PR, Gladman DD, Sanchez-Guerrero J, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Sam Lim S, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Theriault C, Farewell V, Clarke AE. Economic evaluation of lupus nephritis in the Systemic Lupus International Collaborating Clinics inception cohort using a multistate model approach. Arthritis Care Res (Hoboken). 2017 Nov 28. doi: 10.1002/acr.23480. [Epub ahead of print] PubMed PMID: 29193883.
25: Consolim-Colombo FM, Sangaleti CT, Costa FO, Morais TL, Lopes HF, Motta JM, Irigoyen MC, Bortoloto LA, Rochitte CE, Harris YT, Satapathy SK, Olofsson PS, Akerman M, Chavan SS, MacKay M, Barnaby DP, Lesser ML, Roth J, Tracey KJ, Pavlov VA. Galantamine alleviates inflammation and insulin resistance in patients with metabolic syndrome in a randomized trial. JCI Insight. 2017 Jul 20;2(14). pii: 93340. doi: 10.1172/jci.insight.93340. [Epub ahead of print] PubMed PMID: 28724799; PubMed Central PMCID: PMC5518569.
26: Boedigheimer MJ, Martin DA, Amoura Z, Sánchez-Guerrero J, Romero-Diaz J, Kivitz A, Aranow C, Chan TM, Chong YB, Chiu K, Wang C, Sohn W, Arnold GE, Damore MA, Welcher AA, Sullivan BA, Kotzin BL, Chung JB. Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-γ monoclonal antibody, in SLE subjects without or with lupus nephritis. Lupus Sci Med. 2017 Sep 14;4(1):e000226. doi: 10.1136/lupus-2017-000226. eCollection 2017. PubMed PMID: 29018537; PubMed Central PMCID: PMC5604705.
27: Isenberg D, Sturgess J, Allen E, Aranow C, Askanase A, Sang-Cheol B, Bernatsky S, Bruce I, Buyon J, Cervera R, Clarke A, Dooley MA, Fortin P, Ginzler E, Gladman D, Hanly J, Inanc M, Jacobsen S, Kamen D, Khamashta M, Lim S, Manzi S, Nived O, Peschken C, Petri M, Kalunian K, Rahman A, Ramsey-Goldman R, Romero-Diaz J, Ruiz-Irastorza G, Sanchez-Guerrero J, Steinsson K, Sturfelt G, Urowitz M, van Vollenhoven R, Wallace DJ, Zoma A, Merrill J, Gordon C. Study of Flare Assessment in Systemic Lupus Erythematosus Based on Paper Patients. Arthritis Care Res (Hoboken). 2018 Jan;70(1):98-103. doi: 10.1002/acr.23252. Epub 2017 Dec 8. PubMed MID: 28388813; PubMed Central PMCID: PMC5767751.
28: van Vollenhoven R, Voskuyl A, Bertsias G, Aranow C, Aringer M, Arnaud L, Askanase A, Balážová P, Bonfa E, Bootsma H, Boumpas D, Bruce I, Cervera R, Clarke A, Coney C, Costedoat-Chalumeau N, Czirják L, Derksen R, Doria A, Dörner T, Fischer-Betz R, Fritsch-Stork R, Gordon C, Graninger W, Györi N, Houssiau F, Isenberg D, Jacobsen S, Jayne D, Kuhn A, Le Guern V, Lerstrøm K, Levy R, Machado-Ribeiro F, Mariette X, Missaykeh J, Morand E, Mosca M, Inanc M, Navarra S, Neumann I, Olesinska M, Petri M, Rahman A, Rekvig OP, Rovensky J, Shoenfeld Y, Smolen J, Tincani A, Urowitz M, van Leeuw B, Vasconcelos C, Voss A, Werth VP, Zakharova H, Zoma A, Schneider M, Ward M. A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS). Ann Rheum Dis. 2017 Mar;76(3):554-561. doi: 10.1136/annrheumdis-2016-209519. Epub 2016 Nov 24. Review. PubMed PMID: 27884822.
29: Langefeld CD, Ainsworth HC, Cunninghame Graham DS, Kelly JA, Comeau ME, Marion MC, Howard TD, Ramos PS, Croker JA, Morris DL, Sandling JK, Almlöf JC, Acevedo-Vásquez EM, Alarcón GS, Babini AM, Baca V, Bengtsson AA, Berbotto GA, Bijl M, Brown EE, Brunner HI, Cardiel MH, Catoggio L, Cervera R, Cucho-Venegas JM, Dahlqvist SR, D'Alfonso S, Da Silva BM, de la Rúa Figueroa I, Doria A, Edberg JC, Endreffy E, Esquivel-Valerio JA, Fortin PR, Freedman BI, Frostegård J, García MA, de la Torre IG, Gilkeson GS, Gladman DD, Gunnarsson I, Guthridge JM, Huggins JL, James JA, Kallenberg CGM, Kamen DL, Karp DR, Kaufman KM, Kottyan LC, Kovács L, Laustrup H, Lauwerys BR, Li QZ, Maradiaga-Ceceña MA, Martín J, McCune JM, McWilliams DR, Merrill JT, Miranda P, Moctezuma JF, Nath SK, Niewold TB, Orozco L, Ortego-Centeno N, Petri M, Pineau CA, Pons-Estel BA, Pope J, Raj P, Ramsey-Goldman R, Reveille JD, Russell LP, Sabio JM, Aguilar-Salinas CA, Scherbarth HR, Scorza R, Seldin MF, Sjöwall C, Svenungsson E, Thompson SD, Toloza SMA, Truedsson L, Tusié-Luna T, Vasconcelos C, Vilá LM, Wallace DJ, Weisman MH, Wither JE, Bhangale T, Oksenberg JR, Rioux JD, Gregersen PK, Syvänen AC, Rönnblom L, Criswell LA, Jacob CO, Sivils KL, Tsao BP, Schanberg LE, Behrens TW, Silverman ED, Alarcón-Riquelme ME, Kimberly RP, Harley JB, Wakeland EK, Graham RR, Gaffney PM, Vyse TJ. Transancestral mapping and genetic load in systemic lupus erythematosus. Nat Commun. 2017 Jul 17;8:16021. doi: 10.1038/ncomms16021. PubMed PMID: 28714469; PubMed Central PMCID: PMC5520018.
30: Danila MI, Laufer VA, Reynolds RJ, Yan Q, Liu N, Gregersen PK, Lee A, Kern M, Langefeld CD, Arnett DK, Bridges SL Jr. Dense Genotyping of Immune-Related Regions Identifies Loci for Rheumatoid Arthritis Risk and Damage in African Americans. Mol Med. 2017 Jun 29;23. doi: 10.2119/molmed.2017.00081. [Epub ahead of print] PubMed PMID: 28681901; PubMed Central PMCID: PMC5583066.
31: Cui J, Diogo D, Stahl EA, Canhao H, Mariette X, Greenberg JD, Okada Y, Pappas DA, Fulton RS, Tak PP, Nurmohamed MT, Lee A, Larson DE, Kurreeman F, Deluca TL, O'Laughlin M, Fronick CC, Fulton LL, Mardis ER, van der Horst-Bruinsma IE, Wolbink GJ, Gregersen PK, Kremer JM, Crusius JB, de Vries N, Huizinga TW, Fonseca JE, Miceli-Richard C, Karlson EW, Coenen MJ, Barton A, Plenge RM, Raychaudhuri S. Brief Report: The Role of Rare Protein-Coding Variants in Anti-Tumor Necrosis Factor Treatment Response in Rheumatoid Arthritis. Arthritis Rheumatol. 2017 Apr;69(4):735-741. doi: 10.1002/art.39966. PubMed PMID: 27788309.
Northwell Health's various facilities are in safe and pleasant suburban locales. We are close to excellent shopping and diverse dining experiences. While many people own cars, trains and buses permit travel around Long Island but are particularly useful for getting to Manhattan.
On your downtime
With Manhattan just 20 miles to the west and roughly 30 minutes by train, the excitement of Broadway is not far away. Head the other way, and you will find yourself in the vineyards and pastoral settings of eastern Long Island. Head south to the endless beaches on the Atlantic Ocean. Or just a couple of miles north of the hospital you'll find calm bays extending off the Long Island Sound. Whether you like museums, theater, golf, cycling, or boating, Long Island has it all. And, if you want to travel, three major international airports and train stations are nearby.